Cargando...
In Vitro and In Vivo Evaluation of Novel Anticancer Agents in Triple Negative Breast Cancer Models
Triple negative breast cancer (TNBC) is subtype of breast disease devoid of the estrogen, progesterone, and Her2/neu receptors which are targets for pharmacological intervention. There is a need for novel anti-breast cancer agents that target TNBC. Therefore, novel isochalcone DJ52 was evaluated usi...
Gardado en:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3628744/ https://ncbi.nlm.nih.gov/pubmed/23395947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1353/hpu.2013.0047 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|